iCAD, Inc. ICAD announced the first European patients have been treated with the Xoft Axxent® Electronic Brachytherapy System®. Pius-Hospital Oldenburg in Oldenburg, Germany, and Hospital CUF Porto, Portugal, are the first to use the Xoft system in Europe for treating early stage breast cancer. This announcement was made during ESTRO, the annual meeting of the European Society for Radiotherapy & Oncology, taking place May 9-13 in Barcelona, Spain, where iCAD is showcasing the Xoft system.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in